Related Experiment Video
Updated: Jun 19, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Subitem-level multi-scale assessment and machine learning for three-class cognitive status classification in
Ying-Che Chen1, Rwei-Ling Yu2,3,4,5, Sun-Yuan Hsieh6,7,8,9,10,11
1The Institute of Medical Informatics, National Cheng Kung University, Tainan, Taiwan (R.O.C.).
Abstract:
People with Parkinson's disease (PD) frequently develop cognitive impairments, and early accurate classification of cognitive status is critically important for clinical intervention. In this study, we leveraged data from the Parkinson's Progression Markers Initiative (PPMI) to develop a two-stage machine-learning framework that distinguishes among three cognitive states: PD with normal cognition (PD-NC), PD with mild cognitive impairment (PD-MCI), and PD dementia (PDD). Our approach combined SHapley Additive exPlanations (SHAP) for model interpretability with an ensemble of XGBoost and multilayer perceptron (MLP) classifiers, addressing class imbalance via the SMOTE-Tomek method. All model development and validation were conducted with a strict hold-out evaluation, with the test-set entirely excluded from feature selection, model training, and threshold optimization. Independent validation demonstrated strong and balanced classification performance across all cognitive subgroups, with particularly effective identification of cognitively impaired individuals requiring clinical attention. The area under the receiver operating characteristic curve (AUC) for three-class discrimination exceeded 0.85. Key predictors, including Montreal Cognitive Assessment (MoCA) scores and activities of daily living assessments, were validated as clinically meaningful by SHAP analysis. The proposed two-stage explainable model demonstrates strong and balanced classification performance across cognitive subgroups in PD. Its ability to identify people at high risk for dementia highlights its potential utility in clinical workflows, particularly as a scalable tool for early cognitive stratification and decision support in routine neurology practice. However, external validation on diverse real-world cohorts is warranted before clinical implementation.
More Related Videos
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019